1. Kalra, S.P., et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing in vivo. Neuroscience Letters. 194 (3): July 21, 1995; 165-168.
2. Reis, D.J. and S. Regunathan. Agmatine a novel neurotransmitter? Advances in Pharmacology. 42:645-649, 1998.
3. Sener, A., et al. Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine. Biochemical Pharmacology. January 15, 1989. 38(2):327-330.
4. Weitzel G., et al. Insulin-like partial effects of agmatine derivatives in adipocytes. Hoppe-Seylers Zeitschrift fur Physiologische Chemie. January 1980; 361(1):51-60.
5. Morgan, N.G., et al. Characterization of the imidazoline binding site in regulation of insulin secretion. Annals of the New York Academy of Sciences. July 12, 1995. 763:361-373.
6. Yananli H, Goren MZ, Berkman K, Aricioglu F. Effect of agmatine on brain l-citrulline production during morphine withdrawal in rats: A microdialysis study in nucleus accumbens. Brain Res. 2007 Feb 9;1132(1):51-58. Epub 2006 Dec 19. |
|
7. Gao, Y., et al. Agmatine: a novel vasodilator substance. Life Sciences. 1995. 57(8):PL83-86.
8. Lortie, M.J., et al. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. Journal of Clinical Investigation. January 15, 1996; 97(2):413-420.
9. Raasch, W. et al. Agmatine, the bacterial amine is widely distributed in mammalian tissues. Life Sciences. 1995. 56(26):2319-2330.
10. Halaris A, Piletz JE. Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression.
Hum Psychopharmacol. 2001 Jan;16(1):65-69.
11. Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine.
Pharmacol Res. 2004 May;49(5):397-414. Review.
12. Zarandi M, Serfozo P, Zsigo J, Deutch AH, Janaky T, Olsen DB, Bajusz S, Schally AV. Potent agonists of growth hormone-releasing hormone. II.
Pept Res. 1992 Jul-Aug;5(4):190-3. |